nach oben

Drug Safety

Erschienen in:

01.10.2006 | Abstracts

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

verfasst von: L. Muylle, Th. Roisin

Erschienen in: Drug Safety | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Excerpt

Background: Haemovigilance, a requirement of the EU Blood Directive 2002/98/EC, is defined as ‘a set of organised surveillance procedures relating to serious adverse or unexpected events or reactions in donors or recipients of blood components, and the epidemiological follow-up of donors’. Notification is required for serious adverse reactions and, in contrast to the pharmacovigilance systems, for serious adverse events related to blood components. Blood establishments (BE) and hospitals have to report. Its purpose is to identify and prevent events and reactions in the chain from donor to recipient. In 2005 the Belgian Haemovigilance Centre (BHVC) was created in the DGMP-FPSH. …

Titel: ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006
verfasst von: L. Muylle
Th. Roisin
Publikationsdatum: 01.10.2006
Verlag: Springer International Publishing
Erschienen in: Drug Safety / Ausgabe 10/2006
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI: https://doi.org/10.2165/00002018-200629100-00088

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2006